Last updated: 2026-10-12 08:23:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Pulsenmore Ltd. (PLSM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.96, with a market capitalization of $12.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.82 to $12.97. This page covers its latest market performance, valuation, price trends and company information.
$12.03M | |
$1.87 | |
$12.97 | |
$1.82 | |
$1.85 | |
372.00 | |
86.08K | |
-- | |
$12.97 | |
$1.82 | |
-- | |
-- |
Pulsenmore Ltd. (PLSM) is trading at $1.96 in pre-market trading as of 2026-10-12 08:10:00, up 5.68% ($0.10) from the previous close of $1.85
Pre-market trading shows how investors are pricing PLSM before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Pulsenmore Ltd. (PLSM) moved from $2.18 to $1.96, representing a decline of 10.11% ($0.22).
The stock traded between $1.82 and $2.48 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 36.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.2%
PLSM is currently trading at $1.96, placing it 1.2% of the way from its 52-week low of $1.82 to its 52-week high of $12.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
| Employees | 63 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pulsenmore Ltd. (PLSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.